South Korean molecular diagnostics firm Seegene subsidiary Seegene MIDDLE EAST has entered into an exclusive supply agreement with Kuwait’s Ministry of Health. As part of the agreement, Seegene will be providing Covid-19 diagnostic kits worth more than $4.8m to Kuwait. It is expected to be the largest volume of consignment to be procured by the country since a year. Seegene is looking to further expand its global footprint by securing procurement deals with countries such as Italy, Germany, the Middle East, and Scotland.
Ortho Clinical Diagnostics has announced that its VITROS SARS-CoV-2 Antigen Test, has been approved by Health Canada. The test can deliver results on the same day and can run up to 130 tests each hour. It is run on the company’s high-volume VITROS Systems, which are installed across more than 5,600 laboratories globally.
Health technology company binx health announced that it has submitted an Emergency Use Authorization (EUA) request to the US Food and Drug Administration (FDA) for the first Clinical Laboratory Improvement Amendments (CLIA)-waived CRISPR-based point-of-care Covid-19 test. Developed in collaboration with biotechnology company Sherlock Biosciences, the binx io platform is capable of detecting both bacterial and viral infections. If authorised, it is expected to increase access to rapid Covid-19 testing and treatment.